PARAMETRIC PORTFOLIO ASSOCIATES LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 85 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2014. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q1 2016$82,000
-3.5%
78,456
+173.0%
0.00%
Q4 2015$85,000
-4.5%
28,740
+2.5%
0.00%
Q3 2015$89,000
-36.9%
28,040
+17.7%
0.00%
Q2 2015$141,000
-66.5%
23,832
-39.4%
0.00%
-100.0%
Q1 2015$421,000
+82.3%
39,352
+59.9%
0.00%
Q4 2014$231,000
+16.1%
24,611
-4.9%
0.00%
Q3 2014$199,000
-25.5%
25,885
-13.0%
0.00%
-100.0%
Q2 2014$267,000
+86.7%
29,740
+11.1%
0.00%
Q1 2014$143,00026,7800.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2014
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders